Enhance Patient Outcomes with Precision Lifestyle Support
LyfeMD complements biologic medications with expert-led nutrition, mental wellness, and movement support for IBD and inflammatory arthritis patients.
Why Pharma Partners Choose LyfeMD
LyfeMD helps patients manage symptoms, improves adherence, and increases overall satisfaction with biologic therapy through evidence-based lifestyle support.
Leading pharmaceutical companies partner with LyfeMD to:
Improve patient adherence to biologics
Enhance patient-reported outcomes
Strengthen provider confidence
From Clinical Guidelines to Cutting-Edge Care
LyfeMD not only meets clinical practice guidelines but actively contributes to shaping new standards of care. Developed by leading gastroenterologists and rheumatologists, our personalized care approach incorporates the latest research and proven interventions, ensuring your patients receive advanced lifestyle support to optimize treatment outcomes.
Addressing Key
Patient Needs
Managing IBD and inflammatory arthritis can be challenging. Patients often seek extra support with nutrition, fatigue, stress, and daily comfort. LyfeMD provides personalized lifestyle guidance designed to complement medical treatment and help patients feel their best.
We’re different
What Makes LyfeMD Different?
Clinically Validated Results
Patients consistently report meaningful symptom improvement and greater medication adherence.
Expert Clinical Team
Care delivered by Registered Dietitians, licensed therapists, health coaches, and kinesiologists specifically trained in LyfeMD protocols.
Turnkey Partnership
All lifestyle support services under a single, streamlined agreement. No integration hassles, easy to implement.
Established Prescriber Network
Active referral network including Canadian gastroenterologists, rheumatologists, and specialists already referring patients.
Strong Research Foundation
Backed by researchers with more than 400 peer-reviewed publications and decades of combined clinical experience.
Clear Integration,
Real Value
LyfeMD easily integrates into existing patient support programs (PSPs). Our streamlined onboarding ensures minimal disruption and maximum patient benefit. Pharma partners consistently see improved adherence and reduced treatment discontinuation rates, providing measurable value to both patients and stakeholders.
Let's Advance Patient
Care Together
Join pharmaceutical companies, healthcare providers, and research leaders working with LyfeMD to provide holistic, patient-centered support for individuals managing IBD and inflammatory arthritis.
